by John Norman | Feb 23, 2021 | News
Optibrium appoints Dr Rae Lawrence as Director of Software Development • New role will drive development of AI-based drug discovery software solutions and lead development team expansion CAMBRIDGE, UK, 8 February 2021 – Optibrium™, a developer of software for...
by John Norman | Feb 8, 2021 | News
Optibrium Raises Investment to Advance Computer-Aided Drug Discovery • Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process CAMBRIDGE, UK, 8...
by John Norman | Jan 19, 2021 | News
Optibrium Enhances Compound Design Strategies in Major Upgrade to StarDrop Software • New features include reaction-based library enumeration for novel molecule generation and optimisation • AI-integrated with seamless interface to Optibrium’s Artificial Intelligence...
by John Norman | Dec 10, 2020 | News
Optibrium Inspires the Next Generation of Scientists with Practical Industry Experience • Student placement provides invaluable commercial insight and hands-on experience • Educational programme now in its fifth year CAMBRIDGE, UK, 10 December 2020 –...
by John Norman | Dec 3, 2020 | News
Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research CAMBRIDGE, and MACCLESFIELD, UK, 3 December 2020 – The consortium behind...
by John Norman | Nov 10, 2020 | News
Optibrium Enters Cheminformatics Collaboration with MSD CAMBRIDGE, UK, 10 November 2020 – Optibrium™, a developer of software for drug discovery, today announced a collaboration with MSD tradename of Merck & Co., Inc, Kenilworth NJ USA. As part of the...
Recent Comments